Greatmark Investment Partners’s Thermo Fisher Scientific TMO Stock Holding History

Greatmark Investment Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-350	Closed	-$202K	–	135
2023 Q1	$202K	Buy	+350	New	+$197K	0.04%	127
2022 Q2	–	Sell	-350	Closed	-$207K	–	136
2022 Q1	$207K	Sell	350 -275	-44%	-$158K	0.03%	132
2021 Q4	$417K	Hold	625	–	–	0.07%	103
2021 Q3	$357K	Hold	625	–	–	0.07%	106
2021 Q2	$315K	Hold	625	–	–	0.06%	116
2021 Q1	$285K	Sell	625 -225	-26%	-$107K	0.06%	116
2020 Q4	$396K	Sell	850 -100	-11%	-$46.9K	0.09%	99
2020 Q3	$419K	Sell	950 -25	-3%	-$10.3K	0.11%	90
2020 Q2	$353K	Hold	975	–	–	0.09%	96
2020 Q1	$277K	Hold	975	–	–	0.09%	96
2019 Q4	$317K	Buy	975 +4	+0.4%	+$1.21K	0.08%	108
2019 Q3	$283K	Buy	+971	New	+$278K	0.08%	104

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Greatmark Investment Partners's TMO Position: Q2 2023 in Review

Greatmark Investment Partners sold out of Thermo Fisher Scientific (TMO) in Q2 2023, closing a stake of 350 shares — an estimated $202K sold.

Greatmark Investment Partners first reported a position in TMO in Q3 2019 and held it in 12 quarters. The position peaked at $419K in Q3 2020. 2,387 funds tracked by Wall St. Rank hold TMO as of Q2 2023.

Greatmark Investment Partners reported no remaining Thermo Fisher Scientific position as of Q2 2023 after selling out during the quarter.
Greatmark Investment Partners sold 350 Thermo Fisher Scientific shares in Q2 2023, an estimated $202K.
Greatmark Investment Partners first reported a position in Thermo Fisher Scientific in Q3 2019 and held it in 12 quarters.
Greatmark Investment Partners's Thermo Fisher Scientific position peaked at $419K in Q3 2020.
2,387 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2023.

Based on Greatmark Investment Partners's 13F filing for Q2 2023, filed 2 Aug 2023.